Next Article in Journal
Screening of Chinese Medicinal Plants for Inhibition of COX-2 Gene Expression
Previous Article in Journal
Gene Regulatory Effects of Sappan lignum Extract in a Cell Model of Joint Inflammation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 77
Issue 7
10.3797/scipharm.oephg.21.PO-39
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Identification of LL-37 as a Molecular Target for Boswellic Acids

by
A. HENKEL
1,*,
L. TAUSCH
2 and
O. WERZ
1
1
Pharmaceutical Institute, Eberhard Karls University, Auf der Morgenstelle 8, 72076, Tübingen, Germany
2
Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Str. 9, 60438, Frankfurt, Germany
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(7), 238; https://doi.org/10.3797/scipharm.oephg.21.PO-39
Submission received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009
Versions Notes

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Gum resin extracts of Boswellia serrata have been traditionally applied in folk medicine for the treatment of various inflammatory diseases. Analyses of these extracts identified a group of pentacyclic triterpenes, the boswellic acids (BAs), as active principles that might be responsible for some of the observed anti-inflammatory effects.[...]

Share and Cite

MDPI and ACS Style

HENKEL, A.; TAUSCH, L.; WERZ, O. Identification of LL-37 as a Molecular Target for Boswellic Acids. Sci. Pharm. 2009, 77, 238. https://doi.org/10.3797/scipharm.oephg.21.PO-39

AMA Style

HENKEL A, TAUSCH L, WERZ O. Identification of LL-37 as a Molecular Target for Boswellic Acids. Scientia Pharmaceutica. 2009; 77(Posters (PO)):238. https://doi.org/10.3797/scipharm.oephg.21.PO-39

Chicago/Turabian Style

HENKEL, A., L. TAUSCH, and O. WERZ. 2009. "Identification of LL-37 as a Molecular Target for Boswellic Acids" Scientia Pharmaceutica 77, Posters (PO): 238. https://doi.org/10.3797/scipharm.oephg.21.PO-39

APA Style

HENKEL, A., TAUSCH, L., & WERZ, O. (2009). Identification of LL-37 as a Molecular Target for Boswellic Acids. Scientia Pharmaceutica, 77(Posters (PO)), 238. https://doi.org/10.3797/scipharm.oephg.21.PO-39

Article Metrics

Back to TopTop